DBV Technologies (DBVT) Long-Term Debt Repayments (2016 - 2022)
DBV Technologies (DBVT) reported Long-Term Debt Repayments of $5000.0 for Q4 2022, up 102.92% year-over-year from $2464.0 in Q4 2021, and up 103.31% on a QoQ basis from -$151000.0 in Q3 2022.
DBV Technologies (DBVT) has 7 years of Long-Term Debt Repayments data on file, last reported at $5000.0 in Q4 2022.
- Quarterly Long-Term Debt Repayments rose 102.92% year-over-year to $5000.0 in Q4 2022, while the trailing twelve-month figure through Sep 2023 was $5000.0 (up 100.77% YoY) and the FY2022 annual result came in at -$474000.0, up 31.2% from the prior year.
- Long-Term Debt Repayments improved to $5000.0 in Q4 2022 per DBVT's latest filing, from -$151000.0 in the prior quarter.
- Across five years, Long-Term Debt Repayments topped out at $12000.0 in Q2 2020 and bottomed at -$2.1 million in Q4 2018.
- The 5-year median for Long-Term Debt Repayments is -$168000.0 (2022), against an average of -$464280.6.
- The widest annual swing landed in 2021, when Long-Term Debt Repayments plunged 2442.86%; it then surged 102.92% in 2022.
- Tracing DBVT's Long-Term Debt Repayments over 5 years: stood at -$2.1 million in 2018, then soared by 43.57% to -$1.2 million in 2019, then surged by 85.77% to -$165000.0 in 2020, then decreased by 3.64% to -$171000.0 in 2021, then surged by 102.92% to $5000.0 in 2022.
- Per Business Quant, the three latest DBVT Long-Term Debt Repayments figures stand at $5000.0 (Q4 2022), -$151000.0 (Q3 2022), and -$160000.0 (Q2 2022).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Debt Repayments (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | DBV Technologies | 8.00 Bn | 7.77 Bn | -3.90 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 5,000.00 |
| Dec 31, 2022 | 5,000.00 |
| Sep 30, 2022 | -151,000.00 |
| Sep 30, 2022 | -151,000.00 |
| Jun 30, 2022 | -160,000.00 |
| Jun 30, 2022 | -160,000.00 |
| Mar 31, 2022 | -168,000.00 |
| Mar 31, 2022 | -168,000.00 |
| Dec 31, 2021 | -171,000.00 |
| Dec 31, 2021 | -171,000.00 |
| Sep 30, 2021 | -173,000.00 |
| Sep 30, 2021 | -173,000.00 |
| Jun 30, 2021 | -181,000.00 |
| Jun 30, 2021 | -181,000.00 |
| Mar 31, 2021 | -164,000.00 |
| Mar 31, 2021 | -164,000.00 |
| Dec 31, 2020 | -165,000.00 |
| Dec 31, 2020 | -165,000.00 |
| Sep 30, 2020 | -157,000.00 |
| Sep 30, 2020 | -157,000.00 |
| Jun 30, 2020 | 12,000.00 |
| Jun 30, 2020 | 12,000.00 |
| Mar 31, 2020 | 7,000.00 |
| Mar 31, 2020 | 7,000.00 |
| Sep 30, 2019 | -1.16 Mn |
| Sep 30, 2019 | -1.16 Mn |
| Jun 30, 2019 | -1.02 Mn |
| Jun 30, 2019 | -1.02 Mn |
| Dec 31, 2018 | -2.05 Mn |
| Dec 31, 2018 | -2.05 Mn |
| Sep 30, 2018 | -1.42 Mn |
| Sep 30, 2018 | -1.42 Mn |
| Jun 30, 2018 | -773,351.98 |
| Jun 30, 2018 | -773,351.98 |
| Dec 31, 2017 | -680,556.00 |
| Dec 31, 2017 | -680,556.00 |
| Dec 31, 2016 | -296,924.16 |
| Dec 31, 2016 | -296,924.16 |